Johns Hopkins HIV Guide
Trogarzo
INDICATIONS
FDA
FDA
- Treatment of HIV-1 infection in combination with other antiretrovirals in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen
NON-FDA APPROVED USES
NON-FDA APPROVED USES
N/A
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: November 7, 2019
Citation
Bernice, Fidelia. "Trogarzo." Johns Hopkins HIV Guide, 2019. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545276/all/Trogarzo.
Bernice F. Trogarzo. Johns Hopkins HIV Guide. 2019. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545276/all/Trogarzo. Accessed June 2, 2023.
Bernice, F. (2019). Trogarzo. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545276/all/Trogarzo
Bernice F. Trogarzo [Internet]. In: Johns Hopkins HIV Guide. ; 2019. [cited 2023 June 02]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545276/all/Trogarzo.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Trogarzo
ID - 545276
A1 - Bernice,Fidelia,Pharm.D.
Y1 - 2019/11/07/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545276/all/Trogarzo
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
